Foundation for People with Rare Diseases
- Research works
- 6 ▲ 24% vs 2013–17
- Citations
- 212 34.2 per fractional work
- Top-10% rate
- 27.6% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Foundation for People with Rare Diseases is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Foundation for People with Rare Diseases publish most on?
By volume in 2022–2025: RNA modifications and cancer, Cancer Genomics and Diagnostics, Neurogenetic and Muscular Disorders Research and Genetic factors in colorectal cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 RNA modifications and cancer Molecular Biology 0 works
- 2 Cancer Genomics and Diagnostics Cancer Research 0 works
- 3 Neurogenetic and Muscular Disorders Research Genetics 0 works
- 4 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 5 interferon and immune responses Immunology 0 works
- 6 EEG and Brain-Computer Interfaces Cognitive Neuroscience 0 works
- 7 Transcranial Magnetic Stimulation Studies Neurology 0 works
- 8 Neurological disorders and treatments Neurology 0 works
- 9 RNA Research and Splicing Molecular Biology 0 works
- 10 Genomics and Rare Diseases Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Foundation for People with Rare Diseases's research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Schlieren
- Spital Limmattal
- Cell Medica (Switzerland)
- Biognosys (Switzerland)
- Molecular Partners (Switzerland)
- Kuros Biosciences (Switzerland)
- Exalos (Switzerland)
- Neurotune (Switzerland)
- Arcadis (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.